CogniBiome Therapeutics

Startup
United States
Summarized by Halo AI

CogniBiome Therapeutics is a medical technology listed for development and licensing through Tulane University, focused on advancing innovative therapeutic solutions for complex health conditions.

Founded & HQ
Wilmington, DE, USA
Activity highlights
Held its inaugural advisory board meeting on June 8, 2026.

CogniBiome Therapeutics is identified as a technology offering listed within the Tulane University Flintbox portal. The technology relates to advancements in biomedical research, specifically in the development of therapeutic approaches for clinical and research applications. As a listed technology in the university's intellectual property and innovation transfer ecosystem, it is positioned for potential licensing or partnership with industry developers and research collaborators interested in advancing these specific medical technologies.

This technology initiative serves to bridge academic research with practical medical applications, addressing specific health challenges through innovative compounds or treatment methodologies. By providing a framework for intellectual property protection and commercialization, the university facilitates the transition of such early-stage therapeutics from the laboratory setting toward broader development and testing phases, aiming to solve unmet medical needs through targeted therapeutic innovation.

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

DM
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Sponsored researchGift/awardCo-developmentLicensingEquity investmentPilot or trial engagement
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.